Chiklita ad
Friday, 1 September 2017
Kymriah for treating acute lymphoblastic leukemia
Kymriah (tisagenlecleucel) suspension for intravenous infusion, it is a prescription cancer treatment used in patients up to 25 years old who have acute lymphoblastic leukemia (ALL) that is either relapsing or refractory.
Kymriah is made from your white blood cells, your healthcare provider has to take some of your blood called leukapheresis. Your blood cells are frozen and sent to the manufacturing site to make Kymriah.
Your healthcare provider may give you chemotherapy for a few days to prepare your body. When your body is ready, your healthcare provider will give you Kymriah. The drug can increase the risk of life-threatening infections that may lead to death.
Having Kymriah in your blood may cause a false-positive HIV test result by some commercial tests. Kymriah may cause side effects that are life-threatening like: difficulty breathing, fever, shaking chills, confusion, severe nausea, vomiting, diarrhea, severe muscle or joint pain, very low blood pressure and dizziness.
haleplushearty.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment